Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomised Controlled Study to Evaluate the Impact of Novel Glucose Sensing Technology on HbA1c in Type 2 Diabetes

NCT02082184 is registered in ClinicalTrials.gov with Abbott Diabetes Care as lead sponsor.

NCT NCT02082184
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02082184 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomised Controlled Study to Evaluate the Impact of Novel Glucose Sensing Technology on HbA1c in Type 2 Diabetes
Lead sponsor
Abbott Diabetes Care
Phase
Not applicable
Overall status
Completed
Start date
March 31, 2014
Completion date
December 31, 2015
Enrollment
302 (actual)
Sites
26

Conditions

As the registry lists them; a condition with its own page is linked.

type 2 diabetes mellitus